Humana Stock Price, News & Analysis

Humana Inc. (NYSE: HUM) announced a new $25 million investment to enhance affordable housing across the United States, raising its total commitment to $50 million. This investment targets various states including Florida, Georgia, and Illinois, aiming to address housing needs for vulnerable communities. Humana's strategy includes interventions to reduce healthcare costs and improve health outcomes. The funds will be deployed through three syndicated funds utilizing low-income housing tax credits to support construction and rehabilitation of affordable housing.

Humana (NYSE: HUM) hosted the First Pitch, a virtual event linking diverse suppliers with top prime suppliers as part of its Supplier Diversity Mentor Protégé Program. This initiative, active since 2019, aims to enhance opportunities for minority-owned and small businesses. In 2021, Humana invested $345 million in diverse suppliers, a 9% increase from 2020. The event provided participants valuable feedback and potential business opportunities, reinforcing Humana's commitment to fostering relationships that drive innovation and growth.

The Humana Foundation has announced a continued investment of $5.5 million aimed at enhancing health equity outcomes for marginalized populations across six communities in the United States. This initiative, which has spanned over 40 years, focuses on food security, financial wellness, and social connections through local partnerships. Nine organizations will benefit from this funding, which will be allocated based on specific metrics achieved in their respective programs, enhancing community health and wellness for diverse groups.

Humana Inc. (NYSE: HUM) will report its 1Q22 financial results on April 27, 2022, at 6:30 a.m. Eastern time. A conference call will follow at 9:00 a.m. to discuss the results and 2022 earnings guidance. Participants can register in advance for the call via a provided link, and a webcast will be available on Humana's Investor Relations page. The earnings release will include non-GAAP financial measures and a reconciliation to GAAP. Archived presentations will be accessible later on the website.

AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to Humana Inc. (HUM) for its recent issuance of $750 million in 3.70% senior unsecured notes due 2029. The outlook for this rating is stable, and Humana's overall financial health remains unchanged. Proceeds will support general corporate purposes and debt management, with Humana aiming for a more conservative long-term debt-to-capital ratio of 35%. Despite elevated financial leverage at 44%, operating cash flow is strong at $2.3 billion, contributing to favorable revenue growth.

Humana Inc. (NYSE: HUM) has successfully completed a public offering of $750 million in senior notes at a 3.700% interest rate, maturing in 2029. The net proceeds, estimated at $741.1 million, will be used for general corporate purposes, including repaying existing debt. Citigroup Global Markets and Morgan Stanley acted as joint book-running managers for the offering. Forward-looking statements caution investors about various risks, including healthcare cost management, government regulation, and potential impacts from the ongoing COVID-19 pandemic.

Humana Inc. (NYSE: HUM) has announced the pricing of a public offering for $750 million in 3.700% senior notes due 2029. The offering is set to close on March 23, 2022, pending standard closing conditions. The company anticipates net proceeds of approximately $741.1 million, which will be used for general corporate purposes, including repaying existing debts. Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC are the joint book-running managers for this offering. This offering is part of an effective shelf registration with the SEC.

Humana has begun transitioning its Kindred at Home brand to CenterWell Home Health, strengthening its commitment to quality home care. This rebranding effort, initiated on March 1, 2022, will occur across seven states initially, with further expansions planned. The change aims to integrate Kindred's home health services into Humana's overall strategy, enhancing care continuity for patients. CenterWell will serve over 350 locations in 38 states, focusing on improving patient health outcomes and providing personalized care to Medicaid and Medicare patients.

Humana Inc. (NYSE: HUM) has elected David T. Feinberg, M.D., M.B.A., to its Board of Directors. With over 25 years of experience, Feinberg is currently the CEO of Cerner and previously led Google Health, enhancing healthcare initiatives using technology and innovation. Humana's Chairman, Kurt J. Hilzinger, emphasized Feinberg's expertise in improving clinical care and digital transformation as beneficial for the company's growth and strategy execution. This appointment increases Humana's board to 14 members.